Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Anti-CAR Immunity Drives Acquired Therapeutic Resistance to GD2-CAR T Cell Therapy in Diffuse Midline Glioma.
Journal: medRxiv : the preprint server for health sciences
Published: July 17, 2026
Programmable synthetic cytokine receptors polarize macrophages to user-defined functional states.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
Programmable synthetic cytokine receptors polarize macrophages to user-defined functional states.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
CAR T cells for pediatric CNS tumors: Clinical experience and reverse translational opportunities.
Journal: Molecular therapy. Oncology
Published: April 23, 2026
Docetaxel-Induced Myositis in a 16-Year-Old Male With Rhabdomyosarcoma: Case Report and Literature Review.
Journal: Pediatric blood & cancer
Published: January 29, 2026
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 27, 2026
Imaging the efficacy and side effects of CAR T-cell therapy in children and young adults.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: January 09, 2026
Expert Panel Review and Practical Guidance on Biomarker Testing with Engineered Immune Effector Cells.
Journal: Transplantation and cellular therapy
Published: January 05, 2026
The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer.
Journal: Nature reviews. Clinical oncology
Published: December 15, 2025
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies.
Journal: Cytotherapy
Published: May 06, 2025
Last Updated: 09/26/2026